|Articles|June 1, 2003
- BioPharm International-06-02-2003
- Volume 2003 Supplement
- Issue 1
BioPharm International's Virus Inactivation Series: A Preface
Author(s)Shirley I. Miekka, William N. Drohan
by William N. Drohan, Clearant Inc. and Shirley I. Miekka
Advertisement
Articles in this issue
over 22 years ago
Part 1: Skin, Bone, and Cellsover 22 years ago
Part 4: Culture Media, Biotechnology Products, and Vaccinesover 22 years ago
Inactivation of Viruses: An Introduction to the Seriesover 22 years ago
Part 6: Inactivation Methods Grouped by Virusover 22 years ago
Part 5: Disinfectionover 22 years ago
Part 2: Red Blood Cells and PlateletsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
4
Meeting Global Demand and Delivering Faster, More Reliable Service
5

